Description
Research Overview
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog designed to stimulate endogenous growth hormone secretion in controlled laboratory settings. It is commonly studied for its role in pulsatile growth hormone signaling, insulin-like growth factor-1 (IGF-1) modulation, and downstream metabolic regulation pathways.
Unlike native GHRH, CJC-1295 incorporates structural modifications that enhance stability and extend its half-life in vitro, allowing for sustained receptor interaction and prolonged signaling activity. This makes it a valuable compound for research focused on endocrine system dynamics, hormone regulation, and cellular growth signaling mechanisms.
Explore related peptide research in our Research Library.
Scientific Background
CJC-1295 was developed as a long-acting analog of growth hormone-releasing hormone to improve pharmacokinetic stability and enhance growth hormone pulse amplitude in experimental models. It binds to GHRH receptors in the anterior pituitary, stimulating the release of growth hormone through cAMP-mediated signaling pathways.
Research has explored its effects on IGF-1 production, protein synthesis pathways, and metabolic processes including lipid utilization and glucose regulation under controlled laboratory conditions. The compound’s extended activity profile, particularly in DAC-modified forms, has made it a widely studied peptide in endocrine and metabolic research.
Its ability to support sustained growth hormone signaling has positioned CJC-1295 as a key compound in research focused on hormone regulation, aging-related pathways, and cellular recovery mechanisms.
Molecular Information
- Peptide Type: Growth hormone-releasing hormone (GHRH) analog
- Amino Acid Length: 30 amino acids (modified)
- Modification: Stabilized analog (DAC or non-DAC variant depending on formulation)
- Research Classification: Experimental endocrine research compound
- Purity: ≥99% (HPLC verified)
- Appearance: Lyophilized powder
- Storage: Refrigerated (2–8°C); stable ≥30 days post-reconstitution at 4°C
Quality & Analytical Standards
Each batch undergoes analytical verification to confirm identity and purity. Batch-specific Certificates of Analysis (COA) are maintained for all production runs and available upon request.
Research Use Only
This product is intended strictly for laboratory research purposes. Not approved for human or veterinary use. No therapeutic or diagnostic claims are made. BioStrata Research supplies materials exclusively for qualified research and analytical applications.
Reviews
There are no reviews yet.